Paediatric case report of an acquired autoimmune thrombotic thrombocytopenic purpura;Purpura thrombotique thrombocytopénique acquis auto-immun chez l'enfant : à propos d'1 cas

Archives de Pediatrie

Volumn 13, Issue 12, 2006, Pages 1521-1524

  Curtillet, C ^a   Poullin, P ^b   Dore E ^a   Fossat, C ^a   Lefevre, P ^b   Michel, G ^a  

^a TIMONE HOSPITAL   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Child; Rituximab; Thrombotic thrombocytopenic purpura

Indexed keywords

PROTEINASE; PROTEINASE INHIBITOR; RITUXIMAB;

ADOLESCENT; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY DIAGNOSIS; PLASMAPHERESIS; PROGNOSIS; REMISSION; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; AGE FACTORS; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOLOGIC FACTORS; MALE; PLASMA EXCHANGE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; PURPURA, THROMBOTIC THROMBOCYTOPENIC; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 33845406272     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2006.08.012     Document Type: Article

References (16)

1. Moake J.L. Thrombotic microangiopathies. N. Engl. J. Med. 347 (2002) 589-600
2. Tsai H.M., and Lian E.C. Antibodies to von Willebrand factor cleaving protease in acute thrombotic thrombocytopenic purpura. N. Engl. J. Med. 339 (1998) 1585-1594
3. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc. NY Pathol. Soc. 24 (1924) 21-24
4. Veyradier A., and Meyer D. Thrombotic thrombocytopenic purpura and its diagnosis. J. Thromb. Haemost. 3 (2005) 2420-2427
5. Schneppenheim R., Budde U., Hassenpflug W., et al. Severe ADAMTS-13 deficiency in childhood. Semin. Hematol. 41 (2004) 83-89
6. Schneppenheim R., Budde U., Oyen F., et al. Von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP. Blood 101 (2003) 1845-1850
7. Ashida A., Nakamura H., Yoden A., et al. Successful treatment of a young infant who developed high-titer inhibitors against VWF-cleaving protease (ADAMTS-13): important discrimination from Upshaw-Schulman syndrome. Am. J. Hematol. 71 (2002) 318-322
8. Robson W.L., and Tsai H.M. Thrombotic thrombocytopenic purpura attributable to von Willebrand factor-cleaving protease inhibitor in an 8-year-old boy. Pediatrics 109 (2002) 322-325
9. Upshaw Jr. J.D. Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia. N. Engl. J. Med. 298 (1978) 1350-1352
10. Moake J.L., Rudy C.K., Troll J.H., et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N. Engl. J. Med. 307 (1982) 1432-1435
11. Furlan M., Robles R., Galbusera M., et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome. N. Engl. J. Med. 339 (1998) 1578-1584
12. Levy G.G., Motto D.G., and Ginsburg D. ADAMTS13 turns 3. Blood 106 (2005) 11-17
13. George J.N., Sadler J.E., and Lammle B. Platelets: thrombotic thrombocytopenic purpura. Hematology (Am. Soc. Hematol. Educ. Program) 1 (2002) 315-334
14. Yomtovian R., Niklinski W., Silver B., et al. Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature. Br. J. Haematol. 124 (2004) 787-795
15. Sadler J.E., Moake J.L., Miyata T., et al. Recent advances in thrombotic thrombocytopenic purpura. Hematology (Am. Soc. Hematol. Educ. Program) 1 (2004) 407-423
16. Fakhouri F., Vernant J.P., Veyradier A., et al. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13 deficient-thrombotic thrombocytopenic purpura: a study of 11 cases. Blood 106 (2005) 1932-1937